SCHEMBL9498766

SCHEMBL9498766

CNCC1CCC1CNC

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.39
SLC6A4 P31645 2/20 0.33
HTR2A P28223 1/20 0.30
HRH1 P35367 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13165400 1.00 HTR2C (0.39) HTR2CSLC6A4HTR2AHRH1
SCHEMBL24263583 0.84 CA1 (0.38) HTR2C
SCHEMBL24784855 0.82
SCHEMBL26573798 0.82 HTR2C (0.31) HTR2C
SCHEMBL21067464 0.80
SCHEMBL10831129 0.79
SCHEMBL12161918 0.78
SCHEMBL14471663 0.78 HTR2C (0.32) HTR2CSLC6A4
SCHEMBL15888989 0.78 HTR2C (0.32) HTR2C
SCHEMBL16257913 0.78 CA1 (0.33) HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0324154-B1 1,2 BIS(AMINOMETHYL)CYCLOBUTANE-PLATINUM-COMPLEXES ASTA Medica Aktiengesellschaft (DE) 1993-03-17 EP disclosed
US-5023335-A Antitumor agents ASTA PHARMA AKTIENGESELLSCHAFT 1991-06-11 US disclosed